FFT Wealth Management’s AbbVie ABBV Stock Holding History

FFT Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$653K	Hold	2,595	–	–	0.1%	59
2026 Q1	$564K	Hold	2,595	–	–	0.1%	66
2025 Q4	$593K	Hold	2,595	–	–	0.11%	55
2025 Q3	$601K	Hold	2,595	–	–	0.11%	60
2025 Q2	$516K	Hold	2,595	–	–	0.1%	70
2025 Q1	$544K	Sell	2,595 -472	-15%	-$91.8K	0.11%	67
2024 Q4	$545K	Buy	3,067 +41	+1%	+$7.54K	0.04%	88
2024 Q3	$598K	Buy	3,026 +407	+16%	+$76K	0.05%	75
2024 Q2	$449K	Buy	2,619 +32	+1%	+$5.3K	0.04%	83
2024 Q1	$471K	Buy	2,587 +197	+8%	+$34K	0.04%	82
2023 Q4	$370K	Buy	2,390 +115	+5%	+$16.8K	0.03%	75
2023 Q3	$339K	Hold	2,275	–	–	0.04%	57
2023 Q2	$307K	Sell	2,275 -225	-9%	-$33K	0.04%	69
2023 Q1	$398K	Hold	2,500	–	–	0.05%	49
2022 Q4	$404K	Hold	2,500	–	–	0.05%	44
2022 Q3	$336K	Buy	+2,500	New	+$359K	0.05%	51

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FFT Wealth Management's ABBV Position: Q2 2026 in Review

FFT Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,595 shares worth $653K. The position accounts for 0.1% of the portfolio, ranked #59.

FFT Wealth Management first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

FFT Wealth Management held 2,595 shares of AbbVie worth $653K as of Q2 2026.
FFT Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.1% of FFT Wealth Management's portfolio in Q2 2026, its #59 holding.
FFT Wealth Management first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FFT Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.